Clinical Scorecard: Retroperitoneal Spindle Cell Liposarcoma Causing Bowel Obstruction at Presentation

At a Glance

Key Highlights

• Retroperitoneal involvement by spindle cell liposarcoma is uncommon.
• Biopsy with MDM2 amplification supported the diagnosis in this case.
• Multifocal, anatomically extensive disease led the team to defer resection.
• Endoscopic colonic stenting relieved obstruction symptoms and allowed systemic therapy to begin without the anticipated postoperative recovery delay.
• Treatment choice for malignant obstruction should be individualized; stent complications and operative risks were considered.

Guideline-Based Recommendations

Diagnosis

• Use tissue biopsy and appropriate molecular testing; MDM2 amplification helped distinguish this tumor from other spindle cell neoplasms in the reported case.
• Imaging can define disease extent and assess obstruction; PET/CT was used for staging in this case.

Management

• Complete surgical excision is the principal treatment when technically possible.
• Multifocal disease or extension into neighboring structures may prevent complete resection.
• For unresectable disease, systemic anthracycline-based treatment may be considered.
• For malignant bowel obstruction, the source describes individualized choice between surgery and endoscopic stenting according to anatomy, clinical status, available expertise, and treatment goals.

Monitoring & Follow-up

• In this case, repeat CT documented interval progression and sigmoid encasement.
• The source notes potential stent complications, including migration, malposition, perforation, and recurrent obstruction.

Risks

• Retroperitoneal liposarcomas may enlarge considerably before symptoms arise and frequently present at an advanced stage.
• In this case, surgical diversion was expected to involve approximately 2 weeks of recovery before systemic therapy could begin.
• Stenting carries risks including migration, malposition, perforation, and recurrent obstruction.
• Insurance, medication affordability, and transportation difficulties interrupted follow-up in this case.

Patient & Prescribing Data

The reported patient was a 64-year-old Hispanic woman with multifocal, unresectable retroperitoneal spindle cell liposarcoma, ECOG performance status 2, cardiopulmonary comorbidity, and partial large-bowel obstruction.

After endoscopic self-expanding colonic stent placement relieved symptoms, she received doxorubicin and dacarbazine following cardiac evaluation. The article describes this as case-specific management, not a general prescribing regimen.

Clinical Best Practices

• In malignant bowel obstruction, consider obstruction severity, resectability, performance status, operative risk, prognosis, and goals of care; the source describes these as factors in individualized management.
• In this case, the team considered whether postoperative recovery would delay systemic treatment when selecting palliation for unresectable obstruction.
• The source reports insurance coverage, medication costs, and transportation difficulties as barriers to timely care in this case.

Related Resources & Content